{"id":"https://openalex.org/W90056137","doi":null,"title":"Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.","display_name":"Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W90056137","mag":"90056137","pmid":"https://pubmed.ncbi.nlm.nih.gov/15264967"},"language":"en","primary_location":{"id":"pmid:15264967","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15264967","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004451901","display_name":"Andrius Baskys","orcid":"https://orcid.org/0000-0001-6280-5005","observed_orcids":["https://orcid.org/0000-0001-6280-5005"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrius Baskys","raw_affiliation_strings":["Department of Psychiatry and Human Behavior, University of California at Irvine, USA. andrius.baskys@med.va.gov"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Human Behavior, University of California at Irvine, USA. andrius.baskys@med.va.gov","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5004451901"],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":null,"apc_paid":null,"fwci":3.6014,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.91938662,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"65 Suppl 11","issue":null,"first_page":"16","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.06849999725818634,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0674000009894371,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dementia-with-lewy-bodies","display_name":"dementia with Lewy bodies","score":0.925000011920929},{"id":"https://openalex.org/keywords/neuroleptic-sensitivity","display_name":"neuroleptic sensitivity","score":0.8539999723434448},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9380000233650208},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9760000109672546},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neuroleptic-malignant-syndrome","display_name":"neuroleptic malignant syndrome","score":0.9750000238418579},{"id":"https://openalex.org/keywords/agranulocytosis","display_name":"agranulocytosis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/anticholinergic-effects","display_name":"anticholinergic effects","score":0.7919999957084656},{"id":"https://openalex.org/keywords/antipsychotic-tolerability","display_name":"antipsychotic tolerability","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C2778548049","wikidata":"https://www.wikidata.org/wiki/Q101245788","display_name":"Dementia with Lewy bodies","level":4,"score":0.8739831447601318},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.6598687171936035},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.6008749008178711},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.5965967774391174},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5649858713150024},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5076271295547485},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4648759663105011},{"id":"https://openalex.org/C2777964233","wikidata":"https://www.wikidata.org/wiki/Q1424956","display_name":"Neuroleptic malignant syndrome","level":2,"score":0.44785457849502563},{"id":"https://openalex.org/C2779097696","wikidata":"https://www.wikidata.org/wiki/Q1822234","display_name":"Lewy body","level":4,"score":0.447085440158844},{"id":"https://openalex.org/C2910745098","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic agents","level":3,"score":0.43659037351608276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4347115755081177},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.4345892369747162},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.42382198572158813},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.41381487250328064},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.3977179527282715},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.27203214168548584},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24879342317581177},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.24212408065795898},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.18410533666610718}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018849","descriptor_name":"Controlled Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15264967","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15264967","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},{"id":"mag:90056137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15264967","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W3049811","https://openalex.org/W58432556","https://openalex.org/W124662097","https://openalex.org/W1536099628","https://openalex.org/W1796027514","https://openalex.org/W1964183778","https://openalex.org/W1965521527","https://openalex.org/W1985053616","https://openalex.org/W1998495862","https://openalex.org/W2002870445","https://openalex.org/W2002946613","https://openalex.org/W2015728861","https://openalex.org/W2021454992","https://openalex.org/W2022550698","https://openalex.org/W2029153041","https://openalex.org/W2038447514","https://openalex.org/W2051106048","https://openalex.org/W2052826693","https://openalex.org/W2059147823","https://openalex.org/W2060408394","https://openalex.org/W2060802427","https://openalex.org/W2069080061","https://openalex.org/W2077332168","https://openalex.org/W2083220625","https://openalex.org/W2085200241","https://openalex.org/W2089922768","https://openalex.org/W2090236009","https://openalex.org/W2094407307","https://openalex.org/W2099576957","https://openalex.org/W2103964804","https://openalex.org/W2105123756","https://openalex.org/W2114969189","https://openalex.org/W2131977424","https://openalex.org/W2134430627","https://openalex.org/W2136227313","https://openalex.org/W2149722088","https://openalex.org/W2163445625","https://openalex.org/W2170702206","https://openalex.org/W2327942594","https://openalex.org/W2417932067"],"related_works":["https://openalex.org/W2134234211","https://openalex.org/W2315026589","https://openalex.org/W2411003810","https://openalex.org/W1992076394","https://openalex.org/W2059147823","https://openalex.org/W1973214230","https://openalex.org/W1964727464","https://openalex.org/W7222833061","https://openalex.org/W1969911163","https://openalex.org/W1979463290"],"abstract_inverted_index":{"Lewy":[0,9],"body":[1],"dementia,":[2],"also":[3,130],"referred":[4],"to":[5,18,38,99,124,131,156,189,223],"as":[6],"dementia":[7,26,42],"with":[8,153,185,198],"bodies":[10],"(DLB),":[11],"is":[12,45,238],"a":[13,147],"neurodegenerative":[14],"disorder":[15],"now":[16],"considered":[17],"be":[19,76,190],"the":[20,80,100,113,132,172,180,243],"second":[21],"most":[22,106],"common":[23],"cause":[24],"of":[25,40,50,83,105,112,116,136,143,176,182,201,210,217,227,245],"after":[27],"Alzheimer's":[28],"disease.":[29],"Postmortem":[30],"findings":[31],"suggest":[32],"that":[33],"DLB":[34,51,73,94,117,144,228,248],"accounts":[35],"for":[36,150,162,179,242],"20%":[37],"34%":[39],"all":[41],"cases":[43],"and":[44,61,71,85,102,129,159,164,174,193,215,249],"often":[46],"underdiagnosed.":[47],"Salient":[48],"features":[49],"include":[52,66],"fluctuations":[53],"in":[54,247],"cognition,":[55],"perceptual":[56],"abnormalities":[57],"(e.g.,":[58],"visual":[59],"hallucinations),":[60],"mild":[62],"parkinsonism.":[63],"Other":[64],"symptoms":[65,115,127],"frequent":[67],"falls,":[68],"nighttime":[69],"agitation,":[70],"depression.":[72],"symptomatology":[74],"can":[75],"partly":[77],"explained":[78],"by":[79,89],"extensive":[81],"destruction":[82],"dopaminergic":[84],"acetylcholinergic":[86],"pathways":[87],"caused":[88],"neurodegeneration.":[90],"For":[91],"this":[92],"reason,":[93],"patients":[95],"are":[96,121],"especially":[97],"vulnerable":[98],"antidopaminergic":[101],"anticholinergic":[103,213],"actions":[104],"conventional":[107],"antipsychotics,":[108],"which":[109,139],"makes":[110],"treatment":[111,181,244],"psychotic":[114],"extremely":[118],"difficult.":[119],"Patients":[120],"particularly":[122],"sensitive":[123],"developing":[125],"extrapyramidal":[126],"(EPS)":[128],"potentially":[133],"fatal":[134],"complication":[135],"neuroleptic":[137,202,231],"sensitivity,":[138],"affects":[140],"approximately":[141],"50%":[142],"patients.":[145],"Therefore,":[146],"need":[148],"exists":[149],"antipsychotic":[151],"drugs":[152],"less":[154],"propensity":[155],"induce":[157],"EPS":[158],"reduced":[160],"affinity":[161],"dopamine":[163],"acetylcholine":[165],"receptors.":[166],"Here":[167],"we":[168],"review":[169],"studies":[170],"evaluating":[171],"efficacy":[173],"tolerability":[175],"atypical":[177],"antipsychotics":[178],"psychoses":[183,246],"associated":[184,197],"DLB.":[186],"Olanzapine":[187],"appears":[188],"poorly":[191],"tolerated,":[192],"risperidone":[194],"has":[195,220],"been":[196,221],"high":[199],"risk":[200,216],"malignant":[203],"syndrome.":[204],"Clozapine":[205],"use":[206],"remains":[207],"controversial":[208],"because":[209],"its":[211],"potent":[212],"action":[214],"agranulocytosis.":[218],"Quetiapine":[219],"shown":[222],"reduce":[224],"psychiatric":[225],"manifestations":[226],"without":[229],"causing":[230],"sensitivity":[232],"or":[233],"increasing":[234],"EPS.":[235],"Hence,":[236],"quetiapine":[237],"an":[239],"attractive":[240],"candidate":[241],"other":[250],"dementias.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}